Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Product Type
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Deacetylanisomycin is a derivative of the protein and DNA synthesis inhibitor anisomycin (Item No. 11308) with antimalarial and anticancer activity.1,2 It inhibits the growth of the P. falciparum strains K1 and T9-96 in vitro (IC50s = 40.29 and 33.57 μM, respectively).1 Deacetylanisomycin is cytotoxic to LU99 lung carcinoma and MCF-7 breast cancer cells (IC50s = 23 and 34 μM, respectively). It has been used as a negative control for assessment of protein synthesis inhibitor activity in molluscan neurons.3
WARNING This product is not for human or veterinary use.
1. Comparison of the in vitro activities of quassinoids with activity against Plasmodium falciparum, anisomycin and some other inhibitors of eukaryotic protein synthesis. Biochem. Pharmacol. 40(2), 297-301 (1990).
2. Anisomycin and new congeners active against human tumor cell lines. J. Antibiot. (Tokyo) 46(8), 1300-1302 (1993).
3. Inhibition of protein synthesis prolongs Ca2+-